pixantrone has been researched along with 5-methylcytosine in 1 studies
Studies (pixantrone) | Trials (pixantrone) | Recent Studies (post-2010) (pixantrone) | Studies (5-methylcytosine) | Trials (5-methylcytosine) | Recent Studies (post-2010) (5-methylcytosine) |
---|---|---|---|---|---|
92 | 16 | 59 | 2,836 | 7 | 1,892 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bilardi, RA; Chiu, FC; Cutts, SM; Evison, BJ; Pezzoni, G; Phillips, DR | 1 |
1 other study(ies) available for pixantrone and 5-methylcytosine
Article | Year |
---|---|
CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity.
Topics: 5-Methylcytosine; Antibiotics, Antineoplastic; Cell Line, Tumor; CpG Islands; DNA Adducts; DNA Damage; DNA Methylation; DNA-Cytosine Methylases; Doxorubicin; Formaldehyde; Humans; Isoquinolines; Mass Spectrometry | 2009 |